Baxter's (BAX) New Injectables Aid Its Pharmaceutical Portfolio

Baxter International, Inc. (BAX) recently announced the expansion of its Pharmaceutical portfolio with the launch of five injectable products in the United States.The launched products are likely to provide ready-to-use formulations that promote patient needs in key therapeutic areas and benefit healthcare professionals with additional convenience.Price PerformanceIn the past six months, BAX’s shares have rallied 32.3% compared with the industry’s rise of 21.7%. The S&P 500 has gained 19.1% in the same time ...